Nicholas Hoffman & Company’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.74M Sell
24,864
-508
-2% -$35.5K 0.04% 85
2025
Q1
$1.86M Buy
25,372
+22
+0.1% +$1.62K 0.07% 75
2024
Q4
$1.66M Sell
25,350
-304
-1% -$19.9K 0.07% 82
2024
Q3
$2M Buy
25,654
+10
+0% +$779 0.08% 70
2024
Q2
$2M Sell
25,644
-362
-1% -$28.2K 0.09% 65
2024
Q1
$1.76M Buy
26,006
+665
+3% +$45.1K 0.09% 73
2023
Q4
$1.71M Buy
25,341
+475
+2% +$32K 0.1% 69
2023
Q3
$1.68M Buy
24,866
+696
+3% +$47.1K 0.12% 69
2023
Q2
$1.73M Buy
24,170
+201
+0.8% +$14.4K 0.07% 71
2023
Q1
$1.66M Buy
23,969
+14
+0.1% +$972 0.15% 70
2022
Q4
$1.62M Hold
23,955
0.17% 69
2022
Q3
$1.31M Sell
23,955
-50
-0.2% -$2.74K 0.06% 76
2022
Q2
$1.59M Sell
24,005
-546
-2% -$36.1K 0.07% 65
2022
Q1
$1.63M Buy
24,551
+14
+0.1% +$929 0.07% 64
2021
Q4
$1.43M Hold
24,537
0.05% 74
2021
Q3
$1.47M Sell
24,537
-2,424
-9% -$146K 0.26% 68
2021
Q2
$1.62M Hold
26,961
0.29% 62
2021
Q1
$1.34M Sell
26,961
-2,183
-7% -$108K 0.27% 70
2020
Q4
$1.46M Buy
29,144
+1,000
+4% +$50K 0.34% 55
2020
Q3
$1.54M Buy
28,144
+2,250
+9% +$123K 0.41% 45
2020
Q2
$1.37M Buy
25,894
+164
+0.6% +$8.68K 0.39% 50
2020
Q1
$1.15M Sell
25,730
-4,087
-14% -$183K 0.39% 57
2019
Q4
$1.49M Hold
29,817
0.41% 55
2019
Q3
$1.33M Buy
29,817
+1,927
+7% +$85.9K 0.4% 56
2019
Q2
$1.15M Buy
27,890
+2,750
+11% +$113K 0.36% 64
2019
Q1
$1.02M Sell
25,140
-2,877
-10% -$116K 0.33% 73
2018
Q4
$1.06M Sell
28,017
-523
-2% -$19.9K 0.37% 63
2018
Q3
$1.13M Hold
28,540
0.38% 61
2018
Q2
$1M Sell
28,540
-670
-2% -$23.5K 0.37% 68
2018
Q1
$1.02M Sell
29,210
-189
-0.6% -$6.61K 0.4% 63
2017
Q4
$1.02M Hold
29,399
0.4% 64
2017
Q3
$996K Sell
29,399
-354
-1% -$12K 0.42% 65
2017
Q2
$1.01M Buy
29,753
+1,290
+5% +$44K 0.46% 62
2017
Q1
$886K Sell
28,463
-1,647
-5% -$51.3K 0.42% 66
2016
Q4
$834K Buy
30,110
+1,263
+4% +$35K 0.42% 64
2016
Q3
$948K Buy
28,847
+32
+0.1% +$1.05K 0.52% 53
2016
Q2
$870K Buy
+28,815
New +$870K 0.5% 54